Metoprine (BioDeep_00000180918)

   

human metabolite blood metabolite


代谢物信息卡片


2,4-diamino-5-(3,4-Dichlorophenyl)-6-methylpyrimidine

化学式: C11H10Cl2N4 (268.028248)
中文名称: 蛋黄素
谱图信息: 最多检出来源 Homo sapiens(blood) 33.33%

分子结构信息

SMILES: CC1=C(C(=NC(=N1)N)N)C2=CC(=C(C=C2)Cl)Cl
InChI: InChI=1S/C11H10Cl2N4/c1-5-9(10(14)17-11(15)16-5)6-2-3-7(12)8(13)4-6/h2-4H,1H3,(H4,14,15,16,17)

描述信息

C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite
C471 - Enzyme Inhibitor > C2153 - Dihydrofolate Reductase Inhibitor
D004791 - Enzyme Inhibitors > D005493 - Folic Acid Antagonists
D000970 - Antineoplastic Agents

同义名列表

7 个代谢物同义名

2,4-diamino-5-(3,4-Dichlorophenyl)-6-methylpyrimidine; 5-(3,4-dichlorophenyl)-6-methylpyrimidine-2,4-diamine; Methodichlorophen hydrochloride; metoprine, methodichlorophen; Methodichlorophen; Metoprine; DDMP



数据库引用编号

5 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(1)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

1 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有:

  • PubMed: 来源于PubMed文献库中的文献信息,我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表,这个列表按照代谢物同时出现的文献数量降序排序,取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘,得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序,取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中,存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称,可以跳转到相关代谢物的信息页面。



文献列表

  • Mark J Henderson, Kathleen A Trychta, Shyh-Ming Yang, Susanne Bäck, Adam Yasgar, Emily S Wires, Carina Danchik, Xiaokang Yan, Hideaki Yano, Lei Shi, Kuo-Jen Wu, Amy Q Wang, Dingyin Tao, Gergely Zahoránszky-Kőhalmi, Xin Hu, Xin Xu, David Maloney, Alexey V Zakharov, Ganesha Rai, Fumihiko Urano, Mikko Airavaara, Oksana Gavrilova, Ajit Jadhav, Yun Wang, Anton Simeonov, Brandon K Harvey. A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome. Cell reports. 2021 04; 35(4):109040. doi: 10.1016/j.celrep.2021.109040. [PMID: 33910017]
  • Zhen-li Liu, Lin-fu Li, Zhi-qian Song, Chun Wang, Ling Zhang, Zhi-mao Chao. [New chemical constituents from Radix Polygoni Multiflori after processing]. Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials. 2007 Dec; 30(12):1505-7. doi: ". [PMID: 18422181]
  • Eran Bram, Ilan Ifergan, Assaf Shafran, Bluma Berman, Gerrit Jansen, Yehuda G Assaraf. Mutant Gly482 and Thr482 ABCG2 mediate high-level resistance to lipophilic antifolates. Cancer chemotherapy and pharmacology. 2006 Dec; 58(6):826-34. doi: 10.1007/s00280-006-0230-9. [PMID: 16612649]
  • J Jochem. Involvement of arginine vasopressin in endogenous central histamine-induced reversal of critical haemorrhagic hypotension in rats. Inflammation research : official journal of the European Histamine Research Society ... [et al.]. 2004 Jul; 53(7):269-76. doi: 10.1007/s00011-004-1251-7. [PMID: 15241560]
  • Jerzy Jochem. Involvement of the sympathetic nervous system in the reversal of critical haemorrhagic hypotension by endogenous central histamine in rats. Naunyn-Schmiedeberg's archives of pharmacology. 2004 Apr; 369(4):418-27. doi: 10.1007/s00210-004-0883-z. [PMID: 14991226]
  • J Jochem. Involvement of the renin-angiotensin system in endogenous central histamine-induced reversal of critical haemorrhagic hypotension in rats. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society. 2004 Mar; 55(1 Pt 1):39-55. doi: . [PMID: 15082866]
  • J Jochem. Involvement of proopiomenalocortin-derived peptides in endogenous central histamine-induced reversal of critical haemorrhagic hypotension in rats. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society. 2004 Mar; 55(1 Pt 1):57-71. doi: . [PMID: 15082867]
  • A Lecklin, L Eriksson, J Leppäluoto, J Tarhanen, L Tuomisto. Metoprine-induced thirst and diuresis in Wistar rats. Acta physiologica Scandinavica. 1999 Mar; 165(3):325-33. doi: 10.1046/j.1365-201x.1999.00513.x. [PMID: 10192183]
  • A Lecklin, L Tuomisto. The blockade of H1 receptors attenuates the suppression of feeding and diuresis induced by inhibition of histamine catabolism. Pharmacology, biochemistry, and behavior. 1998 Mar; 59(3):753-8. doi: 10.1016/s0091-3057(97)00465-6. [PMID: 9512082]
  • T Irman-Florjanc. Effects of tele-methylhistamine and metoprine on plasma levels of histamine and on its elimination from cat plasma. Inflammation research : official journal of the European Histamine Research Society ... [et al.]. 1997 Mar; 46 Suppl 1(?):S89-90. doi: . [PMID: 9098780]
  • R K Tuominen, L Tuomisto, P T Männistö. Effect of modified brain histamine contents on prolactin and thyrotropin secretion in male rats. European journal of endocrinology. 1996 Feb; 134(2):209-14. doi: 10.1530/eje.0.1340209. [PMID: 8630521]
  • K Okubo, Y Yoshiki. Oxygen-radical-scavenging activity of DDMP-conjugated saponins and physiological role in leguminous plant. Advances in experimental medicine and biology. 1996; 405(?):141-54. doi: 10.1007/978-1-4613-0413-5_12. [PMID: 8910701]
  • A Lecklin, L Tuomisto. Fluid balance in rats of three different strains after inhibition of histamine catabolism. Physiology & behavior. 1995 Nov; 58(5):861-7. doi: 10.1016/0031-9384(95)00131-2. [PMID: 8577881]
  • A Lecklin, M Järvikylä, L Tuomisto. The effect of metoprine on glucoprivic feeding induced by 2-deoxy-D-glucose. Pharmacology, biochemistry, and behavior. 1994 Dec; 49(4):853-7. doi: 10.1016/0091-3057(94)90234-8. [PMID: 7886098]
  • Y G Assaraf, J I Slotky. Characterization of a lipophilic antifolate resistance provoked by treatment of mammalian cells with the antiparasitic agent pyrimethamine. The Journal of biological chemistry. 1993 Feb; 268(6):4556-66. doi: . [PMID: 8440739]
  • N D Baker, R J Griffin, W J Irwin, U Reichert, R Schmidt. Uptake, cytotoxicity and metabolism of m-azidopyrimethamine and related lipophilic antifolates in SV-K14 human keratinocytes in vivo. Biochemical pharmacology. 1991 Dec; 42 Suppl(?):S39-46. doi: 10.1016/0006-2952(91)90390-q. [PMID: 1768284]
  • M C Broughton, S F Queener. Pneumocystis carinii dihydrofolate reductase used to screen potential antipneumocystis drugs. Antimicrobial agents and chemotherapy. 1991 Jul; 35(7):1348-55. doi: 10.1128/aac.35.7.1348. [PMID: 1929292]
  • J Galivan, M S Rhee, T B Johnson, R Dilwith, M G Nair, M Bunni, D G Priest. The role of cellular folates in the enhancement of activity of the thymidylate synthase inhibitor 10-propargyl-5,8-dideazafolate against hepatoma cells in vitro by inhibitors of dihydrofolate reductase. The Journal of biological chemistry. 1989 Jun; 264(18):10685-92. doi: 10.1016/s0021-9258(18)81677-5. [PMID: 2525127]
  • C H Yang, F M Sirotnak, L S Mines. Further studies on a novel class of genetic variants of the L1210 cell with increased folate analogue transport inward. Transport properties of a new variant, evidence for increased levels of a specific transport protein, and its partial characterization following affinity labeling. The Journal of biological chemistry. 1988 Jul; 263(20):9703-9. doi: . [PMID: 2838477]
  • M Nishibori, Y Itoh, R Oishi, K Saeki. Mechanism of the central hyperglycemic action of histamine in mice. The Journal of pharmacology and experimental therapeutics. 1987 May; 241(2):582-6. doi: NULL. [PMID: 3572814]
  • J Laszlo, H J Iland, W D Sedwick. Overcoming methotrexate resistance by a lipophilic antifolate (BW 301U): from theory to models to practice. Advances in enzyme regulation. 1985; 24(?):357-75. doi: 10.1016/0065-2571(85)90086-x. [PMID: 3915188]
  • M R Hamrell. Inhibition of dihydrofolate reductase and cell growth by antifolates in a methotrexate-resistant cell line. Oncology. 1984; 41(5):343-8. doi: 10.1159/000225851. [PMID: 6540852]
  • V Cody. Crystallographic studies of the antineoplastic antifolate 2,4-diamino-5-(3',4'-dichlorophenyl)-6-methylpyrimidine (DDMP) ethanesulfonate salt. Cancer biochemistry biophysics. 1983; 6(3):173-7. doi: ". [PMID: 6850552]
  • R D Serano, C W Sigel, C A Nichol, D D Bigner. Evaluation of the lipid-soluble diaminopyrimidines, metoprine and etoprine, in the avian sarcoma virus rat glioma model. Cancer treatment reports. 1982 Jan; 66(1):99-106. doi: ". [PMID: 6272992]
  • B R Jones, C S Gordon, J Umans, M M Reidenberg, C W Young. Kinetics of metoprine, a lipid-soluble antifolate. British journal of clinical pharmacology. 1981 Nov; 12(5):675-80. doi: 10.1111/j.1365-2125.1981.tb01288.x. [PMID: 7332733]
  • M J Fyfe, W D Sedwick, O E Brown, J Laszlo. Human plasma and amino acids as moderators of uptake and metabolic consequences of antifolates in WIL-2 and human leukemia cells. Journal of the National Cancer Institute. 1981 Mar; 66(3):445-51. doi: NULL. [PMID: 6937701]
  • R de Jager, D Dupont, J J Rodzynek, C Dorlet, G Lagrange. Phase I clinical trial and pharmacology of 2,4-diamino-5-(3',4'-dichlorophenyl)-6-methylpyrimidine (metoprine) (DDMP) and folinic acid (CF). Cancer chemotherapy and pharmacology. 1981; 6(1):75-80. doi: 10.1007/bf00253013. [PMID: 6974058]
  • E M Grivsky, S Lee, C W Sigel, D S Duch, C A Nichol. Synthesis and antitumor activity of 2,4-diamino-6-(2,5-dimethoxybenzyl)-5-methylpyrido[2,3-d]pyrimidine. Journal of medicinal chemistry. 1980 Mar; 23(3):327-9. doi: 10.1021/jm00177a025. [PMID: 6928967]
  • W D Sedwick, M Kutler, T Frazer, O E Brown, J Laszlo. New dose-time relationships of folate antagonists to sustain inhibition of human lymphoblasts and leukemic cells in vitro. Cancer research. 1979 Sep; 39(9):3612-8. doi: ". [PMID: 314333]
  • J R Hindmarsh, R R Hall, A E Kulatilake. Renal cell carcinoma: a preliminary clinical trial of methodichlorophen (D.D.M.P.). Clinical oncology. 1979 Mar; 5(1):11-5. doi: NULL. [PMID: 421383]
  • E M Levin, R B Meyer, V A Levin. Quantitative high-pressure liquid chromatographic procedure for the determination of plasma and tissue levels of 2,4-diamino-5-(3,4-dichlorophenyl)-6-methylpyrimidine (metoprine) and its application to the measurement of brain capillary permeability coefficients. Journal of chromatography. 1978 Aug; 156(1):181-7. doi: 10.1016/s0021-9673(00)83138-6. [PMID: 689956]
  • J C Cavallito, C A Nichol, W D Brenckman, R L Deangelis, D R Stickney, W S Simmons, C W Sigel. Lipid-soluble inhibitors of dihydrofolate reductase. I. Kinetics, tissue distribution, and extent of metabolism of pyrimethamine, metoprine, and etoprine in the rat, dog, and man. Drug metabolism and disposition: the biological fate of chemicals. 1978 May; 6(3):329-37. doi: . [PMID: 26555]
  • J Laszlo, M J Fyfe, D Swedwick, L Lee, O Brown. Comparison of metoprine (DDMP) and etoprine (DDEP) by measuring the inhibition of deoxyuridine incorporation into the DNA of human leukemic cells 1,2,3. Cancer treatment reports. 1978 Mar; 62(3):341-4. doi: . [PMID: 274177]
  • A H Calvert, J S Cridland, K R Harrap. An enzyme inhibition assay for 2,4-diamino-5-(3'4'-dichlorophenyl)-6-methylpyrimidine (DDMP,NSC 19494). Journal of clinical pathology. 1977 Dec; 30(12):1154-7. doi: 10.1136/jcp.30.12.1154. [PMID: 604362]
  • C A Nichol, J C Cavallito, J L Woolley, C W Sigel. Lipid-soluble diaminopyrimidine inhibitors of dihydrofolate reductase. Cancer treatment reports. 1977 Jul; 61(4):559-64. doi: NULL. [PMID: 301777]
  • L A Price, J H Goldie, B T Hill. Methodichlorophen as anti-tumor drug. British medical journal. 1975 Apr; 2(5961):20-1. doi: 10.1136/bmj.2.5961.20. [PMID: 165854]